CollPlant Biotechnologies (CLGN) Competitors $2.45 +0.03 (+1.20%) As of 04/17/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLGN vs. LUCD, OBIO, INFU, MGRM, AVR, MBOT, SRTS, NSPR, FONR, and MLSSShould you be buying CollPlant Biotechnologies stock or one of its competitors? The main competitors of CollPlant Biotechnologies include Lucid Diagnostics (LUCD), Orchestra BioMed (OBIO), InfuSystem (INFU), Monogram Orthopaedics (MGRM), Anteris Technologies Global (AVR), Microbot Medical (MBOT), Sensus Healthcare (SRTS), InspireMD (NSPR), FONAR (FONR), and Milestone Scientific (MLSS). These companies are all part of the "medical equipment" industry. CollPlant Biotechnologies vs. Lucid Diagnostics Orchestra BioMed InfuSystem Monogram Orthopaedics Anteris Technologies Global Microbot Medical Sensus Healthcare InspireMD FONAR Milestone Scientific Lucid Diagnostics (NASDAQ:LUCD) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking, media sentiment and valuation. Does the MarketBeat Community believe in LUCD or CLGN? CollPlant Biotechnologies received 102 more outperform votes than Lucid Diagnostics when rated by MarketBeat users. However, 68.42% of users gave Lucid Diagnostics an outperform vote while only 60.00% of users gave CollPlant Biotechnologies an outperform vote. CompanyUnderperformOutperformLucid DiagnosticsOutperform Votes3968.42% Underperform Votes1831.58% CollPlant BiotechnologiesOutperform Votes14160.00% Underperform Votes9440.00% Which has more volatility and risk, LUCD or CLGN? Lucid Diagnostics has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500. Comparatively, CollPlant Biotechnologies has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Is LUCD or CLGN more profitable? Lucid Diagnostics has a net margin of -1,069.87% compared to CollPlant Biotechnologies' net margin of -2,680.00%. Lucid Diagnostics' return on equity of 0.00% beat CollPlant Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Lucid Diagnostics-1,069.87% N/A -123.54% CollPlant Biotechnologies -2,680.00%-77.05%-61.43% Do analysts prefer LUCD or CLGN? Lucid Diagnostics currently has a consensus target price of $3.40, suggesting a potential upside of 180.99%. CollPlant Biotechnologies has a consensus target price of $12.50, suggesting a potential upside of 416.53%. Given CollPlant Biotechnologies' stronger consensus rating and higher probable upside, analysts plainly believe CollPlant Biotechnologies is more favorable than Lucid Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lucid Diagnostics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20CollPlant Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has better valuation & earnings, LUCD or CLGN? CollPlant Biotechnologies has lower revenue, but higher earnings than Lucid Diagnostics. CollPlant Biotechnologies is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLucid Diagnostics$4.35M25.27-$52.67M-$1.08-1.12CollPlant Biotechnologies$515K53.83-$7.02M-$1.46-1.66 Do institutionals and insiders hold more shares of LUCD or CLGN? 74.0% of Lucid Diagnostics shares are held by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are held by institutional investors. 8.8% of Lucid Diagnostics shares are held by company insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media prefer LUCD or CLGN? In the previous week, Lucid Diagnostics had 3 more articles in the media than CollPlant Biotechnologies. MarketBeat recorded 4 mentions for Lucid Diagnostics and 1 mentions for CollPlant Biotechnologies. Lucid Diagnostics' average media sentiment score of 0.08 beat CollPlant Biotechnologies' score of 0.00 indicating that Lucid Diagnostics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lucid Diagnostics 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CollPlant Biotechnologies 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryLucid Diagnostics beats CollPlant Biotechnologies on 10 of the 18 factors compared between the two stocks. Get CollPlant Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLGN vs. The Competition Export to ExcelMetricCollPlant BiotechnologiesSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$27.72M$8.59B$5.29B$7.35BDividend YieldN/A1.72%5.12%4.31%P/E Ratio-1.5718.6621.7317.77Price / Sales53.8370.67379.1697.65Price / CashN/A19.6738.2234.64Price / Book0.984.846.443.98Net Income-$7.02M$284.66M$3.21B$247.44M7 Day Performance-1.79%1.68%2.81%1.82%1 Month Performance-22.93%-5.79%-8.67%-6.98%1 Year Performance-53.82%-21.24%11.32%1.49% CollPlant Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLGNCollPlant Biotechnologies1.9881 of 5 stars$2.42flat$12.50+416.5%-53.9%$27.72M$515,000.00-1.5770LUCDLucid Diagnostics2.3842 of 5 stars$1.19+1.7%$3.40+185.7%+50.9%$108.00M$4.35M-1.0470High Trading VolumeOBIOOrchestra BioMed1.1839 of 5 stars$2.80-6.0%$15.00+435.7%-38.3%$107.28M$2.64M-1.744Gap DownINFUInfuSystem2.1845 of 5 stars$5.00+0.4%$13.00+160.0%N/A$105.08M$134.86M83.35410Gap DownMGRMMonogram Orthopaedics2.6959 of 5 stars$2.73+8.3%$5.40+97.8%+14.9%$96.34M$364,999.00-5.8128Short Interest ↑Analyst RevisionNews CoverageGap DownAVRAnteris Technologies GlobalN/A$2.58+4.5%$16.50+539.5%N/A$92.94M$2.71M0.00138News CoveragePositive NewsHigh Trading VolumeMBOTMicrobot Medical1.9346 of 5 stars$2.28+2.2%$9.00+294.7%+176.7%$79.22MN/A-2.8520High Trading VolumeSRTSSensus Healthcare2.4939 of 5 stars$4.79+3.9%$13.00+171.4%+41.2%$79.01M$41.81M11.9840NSPRInspireMD2.276 of 5 stars$2.60+1.6%$4.75+82.7%+17.2%$77.19M$7.01M-3.4750High Trading VolumeFONRFONAR1.3079 of 5 stars$12.07-0.2%N/A-25.8%$74.87M$101.57M10.50480Short Interest ↑Negative NewsMLSSMilestone Scientific2.0146 of 5 stars$0.91+1.6%$1.25+36.8%+58.0%$71.19M$8.88M-13.0630Analyst ForecastNews CoverageGap Down Related Companies and Tools Related Companies Lucid Diagnostics Competitors Orchestra BioMed Competitors InfuSystem Competitors Monogram Orthopaedics Competitors Anteris Technologies Global Competitors Microbot Medical Competitors Sensus Healthcare Competitors InspireMD Competitors FONAR Competitors Milestone Scientific Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLGN) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThey Won’t Tell You This About GoldInflation, digital currency, and government policy are quietly eating away at your savings — and most people w...American Alternative | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CollPlant Biotechnologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share CollPlant Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLGN Stock Free CLGN Stock Alerts